TW0004147004
TW0004147004
TAIMED BIOLOGICS INC.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 16.57B EUR | 17.6B EUR | 13.94B EUR | 16.72B EUR |
Enterprise Value | 15.59B EUR | 17.08B EUR | 13.66B EUR | 16.31B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -57.2x | -- | -- | -- |
Price to Sales | 26.74x | 28.4x | 23.19x | 38.43x |
Price to Book | 4.55x | 4.79x | 3.67x | 4.33x |
EV/Revenue | 25.17x | 27.57x | 22.72x | 37.5x |
EV/EBITDA | -398.91x | 672.6x | 353.32x | -- |
Price to FCF (P/FCF) | 78.84x | 163.06x | 179.69x | 132.07x |
EV/FCF | 74.2x | 158.26x | 176.1x | 128.87x |
FCF Yield | 1.27% | 0.61% | 0.56% | 0.76% |